In this sense, not only Dpp-4 hepatic mRNA expression has been reported to be upregulated in patients with non-alcoholic fatty liver disease [52], but also associated with steatohepatitis [53]. This evidence concerns the gene DPP4 and metabolic dysfunction-associated steatotic liver disease.